NEUROENDOCRINE CARCINOMA
Clinical trials for NEUROENDOCRINE CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new NEUROENDOCRINE CARCINOMA trials appear
Sign up with your email to follow new studies for NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo shows promise against rare cancers
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and lenvatinib, in 20 adults with advanced neuroendocrine tumors that had worsened despite prior treatments. The goal was to see if the combination could shrink tumors or slow cancer growth. Participants received the dru…
Matched conditions: NEUROENDOCRINE CARCINOMA
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated May 07, 2026 18:40 UTC
-
PET scan reveals hidden targets in rare, aggressive cancer
Knowledge-focused CompletedThis study looked at 30 people with a rare and aggressive type of neuroendocrine cancer in the digestive system. Researchers used a special PET scan to see if the cancer cells had certain markers (somatostatin receptors) that could be targeted by a future treatment called PRRT. T…
Matched conditions: NEUROENDOCRINE CARCINOMA
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Knowledge-focused
Last updated May 11, 2026 20:51 UTC